With washed mycelium of Streptomyces mediterraπei producing Rifamycin B the transformation of Rifamycin S (SV) to Rifamycin B was investigated [1, 2]. New protein synthesis is not necessary for this reaction, which is connected with the carbohydrate metabolism. On the basis of our experiments Rifamycin S (SV) should be an intermediate in the biosynthesis of Rifamycin B. During the growth of Streptomyces medíterraneí producing Rifamycin B, little amounts of Rifamycin S (SV) could be detected. A mutant strain of Streptomyces medíterraneî, which mainlyproduces Rifamycin S (SV) with and without barbiturate in themedium, was also isolated. With washed mycelium of this newstrain no Rifamycin S (SV) > B transformation occurred. References 1.
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